Curis reported $126.14M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 18520M 865M
AstraZeneca AZN:LN 22.65B 3.6B
Bayer BAYN:GR 38.25B 5.67B
Bristol Myers Squibb BMY:US $ 30121M 3141M
Chimerix CMRX:US 62.55M 33.25M
Curis CRIS:US $ 126.14M 3.76M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Epizyme EPZM:US $ 228.71M 22.66M
Exelixis EXEL:US $ 1842.74M 8M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Spectrum Pharmaceuticals SPPI:US $ 93.18M 10.77M
Takeda 4502:JP Y 2593642M 115749M
Tg Therapeutics TGTX:US $ 242.22M 88.75M
Verastem VSTM:US $ 113.44M 7.7M
Xoma XOMA:US $ 89.61M 7.36M
YTE INCY:US $ 3288.09M 169.42M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M